MARKET RADAR
SENSEX     NIFTY      
Plethico Pharmaceuticals Homepage >> Stock Price >> Plethico Pharma >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages

Plethico Pharmaceuticals

  BSE: 532739  |  NSE: PLETHICO  |  ISIN: INE491H01018
    
Add to Portfolio : Buy Date Qty Price |
368.80 -2.40 (-0.65%)
BSE : Feb 10, 17:00
Open 365.10 Vol 34,808
High 370.50 52 Wk 395.00
Low 365.10 52 Wk 330.55
Prev. Close 371.20    
367.10 -2.75 (-0.74%)
NSE : Feb 10, 17:00
Open 364.60 Vol 31,114
High 371.90 52 Wk 399.00
Low 363.15 52 Wk 313.05
Prev. Close 369.85    
- Related links
Track Plethico Pharmaceuticals 24x7
Get price sensitive and timely news updates on your mobile for just Re 1 a day
Activate Now
  Bid Offer
Price 0.00 368.00
Quantity 0.00 3.00
  Bid Offer
Price 0.00 367.10
Quantity 0.00 154.00
Market Cap 1,256.38 | * EPS (TTM) - | * P/E - | * P/C 396.56
* Book Value 205.26 | * Price/Book 1.80 | Div(%) 25.00 | Div Yield(%) 0.68
Market Lot 1.00 | Face Value 10.00 | Industry P/E 11.00
* As per latest stand alone adjusted profit after extra-ordinary items.

Historic Prices of Plethico Pharma

on 1 week 1 month 3 month 1 year 2 year 3 year
1 YearCurrent% Gain/Loss
Open Price 360.00365.10
High Price 363.85370.50
Low Price 352.25365.10
Last Price 360.90368.802.19
Volume1283434808171.22

Financials of Plethico Pharma

Income Statement (Sep '11) (Dec '10)
  Quarterly Annual
Net Sales 133.21 432.83
Other Income 0.06 0.40
PBDIT 23.33 102.53
Net Profit -22.91 57.91
Profit & Loss | Half Yearly Results | Quarterly Results
Balance Sheet
Total Share Capital 34.07
Net Worth 699.24
Total Debt 581.06
Net Block 136.25
Investments 775.57
Net Current Assets 363.92
Total Assets 1280.29
Balance Sheet | Finished Goods | Raw Materials

Mutual Funds Holding - Plethico Pharma

Scheme No. of Shares
This stock is not held by any Mutual Fund over the last 6 months.

Compare with Peers

What's your call on Plethico Pharma

Experience the thrills of
investing with no risk

Community on Plethico Pharma

News Events - Plethico Pharma

BSE / NSE Notices - Plethico Pharma

Expert Advice - Plethico Pharma

No Expert Advice in the last 7 days

Queries on Plethico Pharma

No Queries in the last 7 days

Groups: Pharmaceuticals

Company Last Price Market Cap
Sun Pharma 541.30 56,056.05
Cipla 349.00 28,021.96
Dr Reddys Labs 1,619.85 27,452.54
Lupin 458.80 20,487.26
Ranbaxy Labs 443.30 18,679.03
more...

Compare with peers

Simple Moving Averages - Plethico Pharma

Days BSE NSE
30 366.99 367.09
50 365.82 365.92
150 369.44 369.52
200 363.64 363.73

Company Facts - Plethico Pharma

Registered Address

A B Road, Manglia
,
Indore
Madhya Pradesh
453771

Tel: 0731-2806271 / 2806275
Fax: 0731-2806271
Email: companysecretary@plethico.com
Website: http://www.plethico.com

Registrars

Link Intime India Pvt. Ltd. C-13, Pannalal Silk Mill Compound,
LBS Marg,
Bhandup (West)

Mumbai - 400078
Maharashtra

Tel: 022-25960320
Fax: 022-25960329
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Plethico Pharma

Name Designation
Shashikant Patel Chairman and Managing director
Gauravi Parikh Executive Director
Pramod Shrivastava Director
Name Designation
Chirag Patel Wholetime Director & CEO
G N Qazi Director
Abhay Suhane Director
Type
S Plethico Pharma
SMS to 51818 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Block Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Exports grow 10.1% in Jan. Will exports take a setback in the coming months?
Yes
No
 

Follow moneycontrol.com